Early versus Conventional Treatment for Patent Ductus Arteriosus in Preterm Infants

被引：3
|
作者：
Candel-Pau, Julla [1 ,2 ]
Linde Sillo, Angeles [2 ]
Castillo Salinas, Felix [2 ]
Coma Redon, Ermengol [3 ]
Ferrer Menduina, Queralt [4 ]
Albert, Dimpna C. [4 ]
机构：
[1] Vail dHebron Res Inst, Neonatol Unit, Barcelona 08035, Spain
[2] Hosp Univ Vail dHebron, Neonatol Unit, Barcelona, Spain
[3] Hosp Univ Vail dHebron, Dept Epidemiol & Prevent Med, Barcelona, Spain
[4] Hosp Univ Vail dHebron, Dept Pediat Cardiol, Barcelona, Spain
来源：
AMERICAN JOURNAL OF PERINATOLOGY | 2013年 / 30卷 / 04期
关键词：
patent ductus arteriosus; indomethacin; early treatment; preterm; BIRTH-WEIGHT INFANTS; SPONTANEOUS INTESTINAL PERFORATION; RESPIRATORY-DISTRESS-SYNDROME; PREMATURE-INFANTS; BRONCHOPULMONARY DYSPLASIA; NECROTIZING ENTEROCOLITIS; INDOMETHACIN PROPHYLAXIS; RISK-FACTORS; DEXAMETHASONE TREATMENT; MANAGEMENT;
D O I：
10.1055/s-0032-1324696
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Objective After the introduction of a new protocol based on the early treatment with indomethacin for patent ductus arteriosus, the objective of this study was to assess the safety and efficacy of this new practice in comparison with the safety and efficacy of the conventional treatment in a high-risk population. Study Design We conducted a retrospective cohort study including 154 newborns with an average gestational age of 26.4 weeks (1.37 standard deviation) and an average birth weight of 855 g (201.5 standard deviation). A statistically descriptive analysis was performed with SPSS Statistics Pack version 17.0. Results and Conclusions We did not find any statistically significant differences in the clinical features of the two treatment groups, nor in the main efficacy, morbidity, and mortality results.
引用
收藏
页码：289 / 295
页数：7
相关论文
共 50 条
  • [1] Patent Ductus Arteriosus in Preterm Infants
    Benitz, William E.
    PEDIATRICS, 2016, 137 (01)
  • [2] Trends and Outcomes of Patent Ductus Arteriosus Treatment in Very Preterm Infants in Canada
    Lokku, Armend
    Mirea, Lucia
    Lee, Shoo K.
    Shah, Prakeshkumar S.
    AMERICAN JOURNAL OF PERINATOLOGY, 2017, 34 (05) : 441 - 450
  • [3] Management of Patent Ductus Arteriosus in Preterm Infants-Where Do We Stand?
    Mitra, Souvik
    Ronnestad, Arild
    Holmstrom, Henrik
    CONGENITAL HEART DISEASE, 2013, 8 (06) : 500 - 512
  • [4] Recent Advances in the Treatment of Preterm Newborn Infants with Patent Ductus Arteriosus
    Sallmon, Hannes
    Koehne, Petra
    Hansmann, Georg
    CLINICS IN PERINATOLOGY, 2016, 43 (01) : 113 - 129
  • [5] Current controversies in the management of patent ductus arteriosus in preterm infants
    Ibrahim, Thowfique K.
    Haium, A. A. Abdul
    Chandran, S.
    Rajadurai, V. S.
    INDIAN PEDIATRICS, 2014, 51 (04) : 289 - 294
  • [6] Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants
    Malviya, Manoj N.
    Ohlsson, Arne
    Shah, Sachin S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (03):
  • [7] Fluid and electrolyte management in preterm infants with patent ductus arteriosus
    Lalitha, R.
    Surak, A.
    Bitar, E.
    Hyderi, A.
    Kumaran, K.
    JOURNAL OF NEONATAL-PERINATAL MEDICINE, 2022, 15 (04) : 689 - 697
  • [8] Indomethacin for symptomatic patent ductus arteriosus in preterm infants
    Evans, Peter
    O'Reilly, Deirdre
    Flyer, Jonathan N.
    Soll, Roger
    Mitra, Souvik
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (01):
  • [9] Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants
    Mitra, Souvik
    Scrivens, Alexandra
    von Kursell, Adelaide M.
    Disher, Tim
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (12):
  • [10] Patent Ductus Arteriosus in Preterm Infants
    Sasi, Arun
    Deorari, Ashok
    INDIAN PEDIATRICS, 2011, 48 (04) : 301 - 308
12345